More on CVA
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net income | -12M |
| Less: Income from discontinued operations, net of tax expense | |
| Income from continuing operations | |
| Depreciation and amortization expense | 155M |
| Amortization of long-term debt deferred financing costs | 5M |
| Amortization of debt premium and discount | |
| Loss on extinguishment of debt | 0 |
| Non-cash convertible debt related expense | |
| Stock-based compensation expense | 13M |
| Equity in net (income) loss from unconsolidated investments | -3M |
| Dividends from unconsolidated investments | 2M |
| Deferred income taxes | 3M |
| Other, net | -3M |
| Change in restricted funds held in trust | |
| Change in working capital, net of effects of acquisitions | -12M |
| Total adjustments for continuing operations | |
| Net cash provided by operating activities from continuing operations | |
| Net cash (used in) provided by operating activities from discontinued operations | |
| Net cash provided by operating activities | 146M |
| Proceeds from the sale of investment securities | |
| Purchase of investment securities | |
| Purchase of property, plant and equipment | -282M |
| Acquisition of noncontrolling interests in subsidiaries | |
| Acquisition of businesses, net of cash acquired | 9M |
| Loan issued for the Harrisburg EfW facility to fund certain facility improvements, net of repayments | |
| Acquisition of land use rights | |
| Other, net | 4M |
| Net cash used in investing activities from continuing operations | |
| Net cash provided by (used in) investing activities from discontinued operations | |
| Net cash provided by (used in) investing activities | -178M |
| Principal payments on long-term debt | -2M |
| Principal payments on project debt | -17M |
| Proceeds from borrowings on project debt | 0 |
| Change in restricted funds held in trust | 19M |
| Proceeds from the exercise of options for common stock, net | |
| Cash dividends paid to stockholders | -98M |
| Common stock repurchased | -20M |
| Distributions to partners of noncontrolling interests in subsidiaries | |
| Other, net | |
| Net cash used in financing activities from continuing operations | |
| Net cash provided by (used in) financing activities from discontinued operations | |
| Net cash used in financing activities | 48M |
| Effect of exchange rate changes on cash and cash equivalents | 1M |
| Net increase (decrease) in cash and cash equivalents | 17M |
| Cash and cash equivalents at beginning of period | 96M |
| Cash and cash equivalents at end of period | 113M |
| Less: Cash and cash equivalents of discontinued operations at end of period | 0 |
| Cash and cash equivalents of continuing operations at end of period | 113M |
Entities mentioned with CVA
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- Barclays | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Trading Radar | View Related Stories »
- Raymond James | View Related Stories »
- Show More...
